HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$37.86
Day range
$36.00 - $38.59
Year range
$13.37 - $38.59
Market cap
1.20B USD
Avg Volume
728.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 193.00K | -89.64% |
Operating expense | 35.12M | 45.93% |
Net income | -31.63M | -79.64% |
Net profit margin | -16.39K | -1,634.02% |
Earnings per share | -0.88 | — |
EBITDA | -34.90M | -57.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 257.39M | -28.64% |
Total assets | 326.08M | -11.62% |
Total liabilities | 23.00M | 114.10% |
Total equity | 303.08M | — |
Shares outstanding | 32.19M | — |
Price to book | 4.02 | — |
Return on assets | -25.88% | — |
Return on capital | -27.53% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -31.63M | -79.64% |
Cash from operations | -23.89M | -64.45% |
Cash from investing | 26.44M | 2,162.19% |
Cash from financing | 568.00K | 125.87% |
Net change in cash | 3.12M | 120.06% |
Free cash flow | -11.54M | -6.31% |
About
Founded
2019
Website
Employees
78